Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1999 Jan 20

PMID 9892616

Citations 182

Authors

M BOZZA

A R Satoskar

G Lin

B Lu

A A Humbles

C Gerard

J R David

Affiliations

Soon will be listed here.

Abstract

To study the biologic role of migration inhibitory factor (MIF), a pleiotropic cytokine, we generated a mouse strain lacking MIF by gene targeting in embryonic stem cells. Analysis of the role of MIF during sepsis showed that MIF-/- mice were resistant to the lethal effects of high dose bacterial lipopolysaccharide (LPS), or Staphylococcus aureus enterotoxin B (SEB) with D-galactosamine and had lower plasma levels of tumor necrosis factor alpha (TNF-alpha) than did wild-type mice, but normal levels of interleukin (IL)-6 and IL-10. When stimulated with LPS and interferon gamma, macrophages from MIF-/- mice showed diminished production of TNF-alpha, normal IL-6 and IL-12, and increased production of nitric oxide. MIF-/- animals cleared gram-negative bacteria Pseudomonas aeruginosa instilled into the trachea better than did wild-type mice and had diminished neutrophil accumulation in their bronchoalveolar fluid compared to the wild-type mice. Thioglycollate elicited peritoneal exudates in uninfected MIF-/- mice, but showed normal neutrophil accumulation. Finally, the findings of enhanced resistance to P. aeruginosa and resistance to endotoxin-induced lethal shock suggest that the counteraction or neutralization of MIF may serve as an adjunct therapy in sepsis.

Citing Articles

Iguratimod, an allosteric inhibitor of macrophage migration inhibitory factor (MIF), prevents mortality and oxidative stress in a murine model of acetaminophen overdose.

Bloom J, Pantouris G, He M, Aljabari B, Mishra L, Manjula R Mol Med. 2024; 30(1):43.

PMID: 38539088 PMC: 10976746. DOI: 10.1186/s10020-024-00803-0.

The Role of Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (D-DT/MIF-2) in Infections: A Clinical Perspective.

Breidung D, Megas I, Freytag D, Bernhagen J, Grieb G Biomedicines. 2024; 12(1).

PMID: 38275363 PMC: 10813530. DOI: 10.3390/biomedicines12010002.

Targeting macrophage migration inhibitory factor (MIF): a promising therapy for inflammatory ocular diseases.

Vazquez A, Gonzalez M, Reyes J J Ophthalmic Inflamm Infect. 2023; 13(1):37.

PMID: 37626184 PMC: 10457254. DOI: 10.1186/s12348-023-00361-2.

OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases.

Thiele M, Donnelly S, Mitchell R J Immunother Cancer. 2022; 10(9).

PMID: 36180072 PMC: 9528626. DOI: 10.1136/jitc-2022-005475.

Macrophage migration inhibitory factor contributes to immunopathogenesis during 17XL infection.

Salazar-Castanon V, Juarez-Avelar I, Legorreta-Herrera M, Rodriguez-Sosa M Front Cell Infect Microbiol. 2022; 12:968422.

PMID: 36093199 PMC: 9449124. DOI: 10.3389/fcimb.2022.968422.

References

Lanahan A, Williams J, Sanders L, Nathans D . Growth factor-induced delayed early response genes. Mol Cell Biol. 1992; 12(9):3919-29. PMC: 360271. DOI: 10.1128/mcb.12.9.3919-3929.1992. View

Vassalli P . The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992; 10:411-52. DOI: 10.1146/annurev.iy.10.040192.002211. View

Porat R, Clark B, Wolff S, Dinarello C . Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science. 1991; 254(5030):430-2. DOI: 10.1126/science.1833820. View

Morrison D, Ryan J . Endotoxins and disease mechanisms. Annu Rev Med. 1987; 38:417-32. DOI: 10.1146/annurev.me.38.020187.002221. View

Lehmann V, Freudenberg M, Galanos C . Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med. 1987; 165(3):657-63. PMC: 2188282. DOI: 10.1084/jem.165.3.657. View

Freudenberg M, Keppler D, Galanos C . Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun. 1986; 51(3):891-5. PMC: 260982. DOI: 10.1128/iai.51.3.891-895.1986. View

Green L, Wagner D, Glogowski J, Skipper P, Wishnok J, Tannenbaum S . Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982; 126(1):131-8. DOI: 10.1016/0003-2697(82)90118-x. View

BOZZA M, Kolakowski Jr L, Jenkins N, Gilbert D, Copeland N, David J . Structural characterization and chromosomal location of the mouse macrophage migration inhibitory factor gene and pseudogenes. Genomics. 1995; 27(3):412-9. DOI: 10.1006/geno.1995.1071. View

Calandra T, Bernhagen J, Metz C, SPIEGEL L, Bacher M, Donnelly T . MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 1995; 377(6544):68-71. DOI: 10.1038/377068a0. View

10.

Wistow G, Shaughnessy M, Lee D, Hodin J, Zelenka P . A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc Natl Acad Sci U S A. 1993; 90(4):1272-5. PMC: 45854. DOI: 10.1073/pnas.90.4.1272. View

11.

Xu H, Gonzalo J, St Pierre Y, Williams I, Kupper T, COTRAN R . Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med. 1994; 180(1):95-109. PMC: 2191562. DOI: 10.1084/jem.180.1.95. View

12.

Buckley T, Nijkamp F . Mucosal exudation associated with a pulmonary delayed-type hypersensitivity reaction in the mouse. Role for the tachykinins. J Immunol. 1994; 153(9):4169-78. View

13.

Bernhagen J, Mitchell R, Calandra T, Voelter W, Cerami A, Bucala R . Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry. 1994; 33(47):14144-55. DOI: 10.1021/bi00251a025. View

14.

Leist M, Gantner F, Bohlinger I, Germann P, Tiegs G, Wendel A . Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol. 1994; 153(4):1778-88. View

15.

Hewett J, Roth R . Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev. 1993; 45(4):382-411. View

16.

Calandra T, Bernhagen J, Mitchell R, Bucala R . The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994; 179(6):1895-902. PMC: 2191507. DOI: 10.1084/jem.179.6.1895. View

17.

Luo G, Niesel D, Shaban R, Grimm E, Klimpel G . Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect Immun. 1993; 61(3):830-5. PMC: 302808. DOI: 10.1128/iai.61.3.830-835.1993. View

18.

Kotzin B, Leung D, Kappler J, Marrack P . Superantigens and their potential role in human disease. Adv Immunol. 1993; 54:99-166. DOI: 10.1016/s0065-2776(08)60534-9. View

19.

Bernhagen J, Calandra T, Mitchell R, Martin S, Tracey K, Voelter W . MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature. 1993; 365(6448):756-9. DOI: 10.1038/365756a0. View

20.

Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J . Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity. 1996; 4(4):407-14. DOI: 10.1016/s1074-7613(00)80254-x. View